Nov, 26 2025
Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
The first generic drug company to file an ANDA with a Paragraph IV certification gets 180 days of market exclusivity-a powerful incentive under the Hatch-Waxman Act. But loopholes let some companies delay launches, blocking competition and keeping prices high.
Read More